Title: Emerging targets in osteoporosis disease modification.
Journal: Journal of medicinal chemistry 20100610
Title: Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial.
Journal: Inflammatory bowel diseases 20100501
Title: An improved synthesis of the selective EP4 receptor agonist ONO-4819.
Journal: The Journal of organic chemistry 20091106
Title: Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
Journal: Bone 20071001
Title: Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
Journal: Cancer research 20061001
Title: Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.
Journal: Bone 20060901
Title: Prostaglandin E2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats.
Journal: The Journal of thoracic and cardiovascular surgery 20060301
Title: Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice.
Journal: European journal of pharmacology 20050725
Title: Up-regulation of lymphocytic cholinergic activity by ONO-4819, a selective prostaglandin EP4 receptor agonist, in MOLT-3 human leukemic T cells.
Journal: Vascular pharmacology 20040301
Title: Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20020402
